These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 34373746)

  • 1. Ligase 1 is a predictor of platinum resistance and its blockade is synthetically lethal in XRCC1 deficient epithelial ovarian cancers.
    Ali R; Alabdullah M; Algethami M; Alblihy A; Miligy I; Shoqafi A; Mesquita KA; Abdel-Fatah T; Chan SY; Chiang PW; Mongan NP; Rakha EA; Tomkinson AE; Madhusudan S
    Theranostics; 2021; 11(17):8350-8361. PubMed ID: 34373746
    [No Abstract]   [Full Text] [Related]  

  • 2. PARP1 blockade is synthetically lethal in XRCC1 deficient sporadic epithelial ovarian cancers.
    Ali R; Alabdullah M; Alblihy A; Miligy I; Mesquita KA; Chan SY; Moseley P; Rakha EA; Madhusudan S
    Cancer Lett; 2020 Jan; 469():124-133. PubMed ID: 31669203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative Okazaki Fragment Ligation Pathway by DNA Ligase III.
    Arakawa H; Iliakis G
    Genes (Basel); 2015 Jun; 6(2):385-98. PubMed ID: 26110316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HPF1-dependent PARP activation promotes LIG3-XRCC1-mediated backup pathway of Okazaki fragment ligation.
    Kumamoto S; Nishiyama A; Chiba Y; Miyashita R; Konishi C; Azuma Y; Nakanishi M
    Nucleic Acids Res; 2021 May; 49(9):5003-5016. PubMed ID: 33872376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mammalian DNA ligases; roles in maintaining genome integrity.
    Sallmyr A; Bhandari SK; Naila T; Tomkinson AE
    J Mol Biol; 2024 Jan; 436(1):168276. PubMed ID: 37714297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA ligase III is critical for mtDNA integrity but not Xrcc1-mediated nuclear DNA repair.
    Gao Y; Katyal S; Lee Y; Zhao J; Rehg JE; Russell HR; McKinnon PJ
    Nature; 2011 Mar; 471(7337):240-4. PubMed ID: 21390131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human DNA ligases I and III have stand-alone end-joining capability, but differ in ligation efficiency and specificity.
    McNally JR; Ames AM; Admiraal SJ; O'Brien PJ
    Nucleic Acids Res; 2023 Jan; 51(2):796-805. PubMed ID: 36625284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crucial role for DNA ligase III in mitochondria but not in Xrcc1-dependent repair.
    Simsek D; Furda A; Gao Y; Artus J; Brunet E; Hadjantonakis AK; Van Houten B; Shuman S; McKinnon PJ; Jasin M
    Nature; 2011 Mar; 471(7337):245-8. PubMed ID: 21390132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ERCC1-XPF deficiency is a predictor of olaparib induced synthetic lethality and platinum sensitivity in epithelial ovarian cancers.
    Mesquita KA; Alabdullah M; Griffin M; Toss MS; Fatah TMAA; Alblihy A; Moseley P; Chan SYT; Rakha EA; Madhusudan S
    Gynecol Oncol; 2019 May; 153(2):416-424. PubMed ID: 30797591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Mre11 overcomes platinum resistance and induces synthetic lethality in XRCC1 deficient epithelial ovarian cancers.
    Alblihy A; Ali R; Algethami M; Shoqafi A; Toss MS; Brownlie J; Tatum NJ; Hickson I; Moran PO; Grabowska A; Jeyapalan JN; Mongan NP; Rakha EA; Madhusudan S
    NPJ Precis Oncol; 2022 Jul; 6(1):51. PubMed ID: 35853939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ataxia telangiectasia mutated and Rad3 related (ATR) protein kinase inhibition is synthetically lethal in XRCC1 deficient ovarian cancer cells.
    Sultana R; Abdel-Fatah T; Perry C; Moseley P; Albarakti N; Mohan V; Seedhouse C; Chan S; Madhusudan S
    PLoS One; 2013; 8(2):e57098. PubMed ID: 23451157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA ligase III promotes alternative nonhomologous end-joining during chromosomal translocation formation.
    Simsek D; Brunet E; Wong SY; Katyal S; Gao Y; McKinnon PJ; Lou J; Zhang L; Li J; Rebar EJ; Gregory PD; Holmes MC; Jasin M
    PLoS Genet; 2011 Jun; 7(6):e1002080. PubMed ID: 21655080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular disruption of DNA polymerase β for platinum sensitisation and synthetic lethality in epithelial ovarian cancers.
    Ali R; Alblihy A; Miligy IM; Alabdullah ML; Alsaleem M; Toss MS; Algethami M; Abdel-Fatah T; Moseley P; Chan S; Mongan NP; Narayan S; Rakha EA; Madhusudan S
    Oncogene; 2021 Apr; 40(14):2496-2508. PubMed ID: 33674744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human DNA ligases in replication and repair.
    Sallmyr A; Rashid I; Bhandari SK; Naila T; Tomkinson AE
    DNA Repair (Amst); 2020 Sep; 93():102908. PubMed ID: 33087274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deficiency of ligase IV leads to reduced NHEJ, accumulation of DNA damage, and can sensitize cells to cancer therapeutics.
    Kumari N; Antil H; Kumari S; Raghavan SC
    Genomics; 2023 Nov; 115(6):110731. PubMed ID: 37871849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ARL6IP5 reduces cisplatin-resistance by suppressing DNA repair and promoting apoptosis pathways in ovarian carcinoma.
    Kim JY; Bahar E; Lee JY; Chang S; Kim SH; Park EY; Do SI; Yoon H; Kim HS
    Cell Death Dis; 2022 Mar; 13(3):239. PubMed ID: 35293383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligase I and ligase III mediate the DNA double-strand break ligation in alternative end-joining.
    Lu G; Duan J; Shu S; Wang X; Gao L; Guo J; Zhang Y
    Proc Natl Acad Sci U S A; 2016 Feb; 113(5):1256-60. PubMed ID: 26787905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological and functional significance of XRCC1 expression in ovarian cancer.
    Abdel-Fatah T; Sultana R; Abbotts R; Hawkes C; Seedhouse C; Chan S; Madhusudan S
    Int J Cancer; 2013 Jun; 132(12):2778-86. PubMed ID: 23225521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ku70 suppresses alternative end joining in G1-arrested progenitor B cells.
    Liang Z; Kumar V; Le Bouteiller M; Zurita J; Kenrick J; Lin SG; Lou J; Hu J; Ye AY; Boboila C; Alt FW; Frock RL
    Proc Natl Acad Sci U S A; 2021 May; 118(21):. PubMed ID: 34006647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic analyses of single-stranded break repair by human DNA ligase III isoforms reveal biochemical differences from DNA ligase I.
    McNally JR; O'Brien PJ
    J Biol Chem; 2017 Sep; 292(38):15870-15879. PubMed ID: 28751376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.